Pfizer Covid-19 vaccine on track for regulatory review in October
The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. (Representational image: Reuters)Pfizer Inc. and BioNTech SE said the Covid-19…